| CXCR1-or CXCR2-modified CAR T cells co-opt IL-8 for maximal antitumor efficacy in solid tumors L Jin, H Tao, A Karachi, Y Long, AY Hou, M Na, KA Dyson, AJ Grippin, ... Nature communications 10 (1), 4016, 2019 | 314 | 2019 |
| Mechanical characterization of human brain tumors from patients and comparison to potential surgical phantoms DC Stewart, A Rubiano, K Dyson, CS Simmons PloS one 12 (6), e0177561, 2017 | 143 | 2017 |
| Dysregulation of glutamate transport enhances treg function that promotes VEGF blockade resistance in glioblastoma Y Long, H Tao, A Karachi, AJ Grippin, L Jin, Y Chang, W Zhang, ... Cancer research 80 (3), 499-509, 2020 | 100 | 2020 |
| Emerging trends in immunotherapy for pediatric sarcomas KA Dyson, BD Stover, A Grippin, HR Mendez-Gomez, J Lagmay, ... Journal of hematology & oncology 12, 1-10, 2019 | 86 | 2019 |
| Dendritic cell-activating magnetic nanoparticles enable early prediction of antitumor response with magnetic resonance imaging AJ Grippin, B Wummer, T Wildes, K Dyson, V Trivedi, C Yang, ... ACS nano 13 (12), 13884-13898, 2019 | 78 | 2019 |
| Cross-talk between T cells and hematopoietic stem cells during adoptive cellular therapy for malignant glioma TJ Wildes, A Grippin, KA Dyson, BM Wummer, DJ Damiani, RS Abraham, ... Clinical Cancer Research 24 (16), 3955-3966, 2018 | 40 | 2018 |
| Chronic traumatic encephalopathy: update on current clinical diagnosis and management K Pierre, K Dyson, A Dagra, E Williams, K Porche, B Lucke-Wold Biomedicines 9 (4), 415, 2021 | 38 | 2021 |
| Immune escape after adoptive T-cell therapy for malignant gliomas TJ Wildes, KA Dyson, C Francis, B Wummer, C Yang, O Yegorov, D Shin, ... Clinical Cancer Research 26 (21), 5689-5700, 2020 | 37 | 2020 |
| Origin recognition is the predominant role for DnaA-ATP in initiation of chromosome replication JE Grimwade, TA Rozgaja, R Gupta, K Dyson, P Rao, AC Leonard Nucleic acids research 46 (12), 6140-6151, 2018 | 28 | 2018 |
| RNA-modified T cells mediate effective delivery of immunomodulatory cytokines to brain tumors F Pohl-Guimarães, C Yang, KA Dyson, TJ Wildes, J Drake, J Huang, ... Molecular Therapy 27 (4), 837-849, 2019 | 25 | 2019 |
| FGFR1 N546K and H3F3A K27M mutations in a diffuse leptomeningeal tumour with glial and neuronal markers. K Dyson, M Rivera‐Zengotita, J Kresak, K Weaver, B Stover, J Fort, ... Histopathology 69 (4), 2016 | 22 | 2016 |
| mRNA-based precision targeting of neoantigens and tumor-associated antigens in malignant brain tumors V Trivedi, C Yang, K Klippel, O Yegorov, C von Roemeling, L Hoang-Minh, ... Genome Medicine 16 (1), 17, 2024 | 12 | 2024 |
| Training methods that improve MD–PhD student self-efficacy for clinical research skills M Sebastian, MA Robinson, L Dumeny, KA Dyson, JC Fantone, ... Journal of Clinical and Translational Science 3 (6), 316-324, 2019 | 11 | 2019 |
| Effect of atorvastatin on humoral immune response to 23-valent pneumococcal polysaccharide vaccination in healthy volunteers: the StatVax randomized clinical trial TJ Wildes, A Grippin, H Fasanya, KA Dyson, M Brantly Vaccine 37 (10), 1313-1324, 2019 | 8 | 2019 |
| Nanoparticles as immunomodulators and translational agents in brain tumors AJ Grippin, KA Dyson, S Qdaisat, J McGuiness, B Wummer, DA Mitchell, ... Journal of Neuro-oncology 151, 29-39, 2021 | 7 | 2021 |
| CXCR1-or CXCR2-modified CAR T cells co-opt IL-8 for maximal antitumor efficacy in solid tumors. Nat. Commun. 10, 4016 L Jin, H Tao, A Karachi, Y Long, AY Hou, M Na, KA Dyson, AJ Grippin, ... Molecular Therapy: Methods & Clinical Development, 2019 | 7 | 2019 |
| Versatile mRNA-nanoparticle platform for treatment of glioblastoma A Grippin, B Wummer, T Wildes, K Dyson, H Méndez-Gómez, J Dobson, ... International Journal of Radiation Oncology, Biology, Physics 111 (3), e251-e252, 2021 | 3 | 2021 |
| Identification of tumor rejection antigens and the immunologic landscape of medulloblastoma C Yang, V Trivedi, K Dyson, T Gu, KM Candelario, O Yegorov, DA Mitchell Genome Medicine 16 (1), 102, 2024 | 1 | 2024 |
| Immu-41. Versatile mRNA-Nanoparticle Platform to Reprogram the Brain Tumor Microenvironment and Predict Treatment Outcome A Grippin, H Mendez-Gomez, B Wummer, F Weidert, T Wildes, K Dyson, ... Neuro-Oncology 24 (Suppl 7), vii140, 2022 | 1 | 2022 |
| Adoptive cellular therapy overcomes tumor-induced dysregulation of myelopoiesis TJ Wildes, CT Flores, BDV Dean, A Grippin, K Dyson, DA Mitchell Cancer Research 79 (13_Supplement), 1194-1194, 2019 | 1 | 2019 |
Duane MitchellPhyllis Kottler Friedman Professor, University of FloridaEmail được xác minh tại neurosurgery.ufl.edu